Conformis: Rises on upbeat preliminary Q3 rev
** Medical device maker's shares CFMS.O rise 8% to 80
cents in premarket trade
** Reports preliminary Q3 rev of $16.1 mln vs est of $13 mln
- Refinitiv data urn:newsml:reuters.com:*:nGNXfdZ2F
** In the quarter, there was continued resumption of
elective primary joint replacement surgery - CEO Mark Augusti
** Scheduled to report results on Nov. 4
** Stock down 50% YTD
(Reporting by Shreyasee Raj in Bengaluru)
((Shreyasee.Raj@thomsonreuters.com;))
Recent news on ConforMIS
See all newsBrief: Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Conformis Stockholders Vote “For” The Pending Merger With Restored
Brief: Proxy Advisory Firm Iss Recommends Conformis Stockholders Vote “For” The Pending Merger With Restor3d
Conformis Inc reports results for the quarter ended in June - Earnings Summary
U.S. RESEARCH ROUNDUP- Booking Holdings, Monster Beverage, Topbuild
U.S. STOCKS ON THE MOVE-Graphite Bio, Leggett & Platt, Nauticus Robotics